Skip to Main Navigation

Honduras COVID-19 Emergency Response Project

Abstract*

This project supports the COVID-19 response plan for Honduras, under the Fast Track COVID-19 Facility. The Project components are aligned with the objectives of the COVID-19 SPRP and will support the Government’s capacity to detect and respond to the threat posed by COVID-19. The specific activities financed by the Project fit into the overall Government strategy to support the identification, isolation, and provision of care for patients with COVID-19...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To detect and respond to the threat posed by COVID-19 in the Republic of Honduras.

Key Details

Project Details

  • P173861

  • Closed

  • Nicolas Collin Dit De Montesson , Courtney Ivins

  • Republic of Honduras

  • Honduras

  • April 9, 2020

  • (as of board presentation)

    April 15, 2020

  • May 28, 2020

  • US$ 20.00 million

  • N/A

  • Substantial

  • October 31, 2024

  • No

  • BANK APPROVED

  • April 25, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 20.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 20.00
IBRD + IDA Commitment 20.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 20.00

Summary Status of World Bank Financing (US$ Millions) as of June 30, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of June 30, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Mar 1, 2023 IDA-68680 Loan Disb 4,000,000.00
May 4, 2023 IDA-66260 Loan Disb 176,416.20
Apr 15, 2023 IDA-68680 Int Charges 14,102.92
Aug 15, 2023 IDA-66260 Loan Disb 600,000.00
Sep 13, 2023 IDA-68680 Loan Disb 350,679.06
Sep 28, 2023 IDA-66260 Loan Disb 821,545.00
Jul 6, 2023 IDA-68680 Loan Disb 1,800,000.00
Mar 1, 2024 IDA-66260 Loan Disb -927,797.40
Mar 25, 2024 IDA-66260 Loan Disb 417,595.16
Mar 25, 2024 IDA-68680 Loan Disb 643,023.50
Aug 26, 2024 IDA-68680 Loan Disb 156,293.44
May 10, 2024 IDA-68680 Loan Disb 4,287,339.00
Jun 27, 2024 IDA-66260 Loan Disb 1,390,512.50
Dec 27, 2023 IDA-68680 Loan Disb 191,391.69
Apr 15, 2024 IDA-68680 Int Charges 1,287.13
Apr 15, 2024 IDA-68680 Int Charges 114,799.35
Apr 15, 2024 IDA-68680 Int Charges 114,799.35
Apr 15, 2024 IDA-68680 Int Charges 92,761.49
Apr 15, 2024 IDA-66260 Int Charges 3,664.19
Apr 15, 2024 IDA-66260 Int Charges 120,108.40
Apr 15, 2024 IDA-66260 Int Charges 120,108.40
Apr 15, 2024 IDA-66260 Int Charges 125,694.83
Jun 5, 2023 IDA-68680 Loan Disb 600,784.20
Jul 19, 2023 IDA-68680 Loan Disb 40,793.94
Oct 15, 2023 IDA-66260 Int Charges 110,841.68
Jun 8, 2023 IDA-66260 Loan Disb 536,909.40
Dec 26, 2023 IDA-68680 Loan Disb 1,124,385.50
Dec 26, 2023 IDA-66260 Loan Disb 417,594.80
Oct 15, 2023 IDA-66260 Int Charges 109,416.72
Oct 15, 2023 IDA-66260 Int Charges 109,416.72
Oct 15, 2023 IDA-68680 Int Charges 77,792.37
Oct 15, 2023 IDA-68680 Int Charges 77,792.37
Oct 15, 2023 IDA-68680 Int Charges 62,319.57
Oct 19, 2023 IDA-68680 Loan Disb 20,441.16
Oct 3, 2023 IDA-68680 Loan Disb 314,484.90
Oct 15, 2023 IDA-68680 Int Charges 15,106.67
Dec 21, 2023 IDA-66260 Loan Disb 417,595.50
Dec 21, 2023 IDA-68680 Loan Disb 368,218.56
Nov 14, 2023 IDA-68680 Loan Disb 1,960,000.00
Apr 15, 2023 IDA-66260 Int Charges 108,159.99
Apr 15, 2023 IDA-68680 Int Charges 5,943.95
Apr 15, 2023 IDA-68680 Int Charges 5,943.95
Apr 15, 2023 IDA-68680 Int Charges 4,860.08
Apr 15, 2023 IDA-68680 Int Charges 35,723.95
Apr 15, 2023 IDA-68680 Int Charges 35,723.95
Apr 15, 2023 IDA-66260 Int Charges 103,352.88
Apr 15, 2023 IDA-66260 Int Charges 103,352.88
Aug 31, 2022 IDA-68680 Loan Disb 2,780,000.00
Oct 15, 2022 IDA-66260 Int Charges 102,128.48
Oct 15, 2022 IDA-66260 Int Charges 102,128.48
Oct 15, 2022 IDA-66260 Int Charges 106,878.65
Sep 26, 2022 IDA-68680 Loan Disb 22,526.10
Dec 7, 2022 IDA-66260 Loan Disb 28,651.00
Dec 7, 2022 IDA-66260 Loan Disb 118,730.80
Oct 13, 2022 IDA-68680 Loan Disb 36,227.55
Oct 6, 2022 IDA-68680 Loan Disb 16,535.90
Nov 4, 2022 IDA-66260 Loan Disb 78,346.08
Apr 25, 2023 IDA-68680 Loan Disb 164,617.00
Feb 10, 2023 IDA-66260 Loan Disb 117,519.12
Apr 15, 2022 IDA-66260 Int Charges 96,830.54
Apr 15, 2022 IDA-66260 Int Charges 96,830.54
May 3, 2022 IDA-66260 Loan Disb 800,000.00
Aug 30, 2021 IDA-66260 Loan Disb -320.00
Apr 15, 2022 IDA-66260 Int Charges 101,335.40
Apr 15, 2022 IDA-66260 Int Charges 1.05
Apr 15, 2022 IDA-66260 Int Charges 1.05
Jul 21, 2022 IDA-66260 Loan Disb -201,548.42
Aug 26, 2022 IDA-68680 Loan Disb 2,502.90
Dec 27, 2022 IDA-68680 Loan Disb 286,031.50
Dec 27, 2022 IDA-68680 Loan Disb 326,047.94
Apr 30, 2021 IDA-66260 Loan Disb 88,515.00
May 10, 2021 IDA-66260 Loan Disb 49,653.89
Oct 15, 2021 IDA-66260 Int Charges 5,600.93
Oct 15, 2021 IDA-66260 Int Charges 92,034.38
Oct 15, 2021 IDA-66260 Int Charges 92,034.38
Oct 15, 2021 IDA-66260 Int Charges 96,315.08
Apr 15, 2021 IDA-66260 Int Charges 7,234.94
Apr 15, 2021 IDA-66260 Int Charges 7,234.94
Apr 15, 2021 IDA-66260 Int Charges 7,571.46
Apr 15, 2021 IDA-66260 Int Charges 52,660.22
Apr 15, 2021 IDA-66260 Int Charges 52,660.22
Apr 15, 2021 IDA-66260 Int Charges 49,508.59
Nov 23, 2021 IDA-66260 Loan Disb 925,000.00
Aug 31, 2020 IDA-66260 Loan Disb 3,993,010.00
Sep 2, 2020 IDA-66260 Loan Disb 61,000.00
Dec 21, 2020 IDA-66260 Loan Disb 1,550,137.20
Sep 8, 2020 IDA-66260 Loan Disb 529,652.50
Dec 21, 2020 IDA-66260 Loan Disb 49,991.34
Mar 23, 2021 IDA-66260 Loan Disb 3,432,071.00
Dec 29, 2020 IDA-66260 Loan Disb 819,447.90
Jan 22, 2021 IDA-66260 Loan Disb 3,600,904.50
Apr 7, 2021 IDA-66260 Loan Disb 108,867.00
Apr 15, 2020 IDA-66260 Loan Commitment 20,000,000.00
Apr 16, 2021 IDA-68680 Loan Commitment 20,000,000.00

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Financial Management Satisfactory 2025-01-28
Monitoring and Evaluation Satisfactory 2025-01-28
Overall Implementation Progress (IP) Satisfactory 2025-01-28
Progress towards achievement of PDO Highly Satisfactory 2025-01-28
Procurement Satisfactory 2025-01-28
Project Management Satisfactory 2025-01-28

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Designated laboratories with COVID-19 diagnostic equipment, test kits, and reagentsValue0.001.001.00
    DateApril 1, 2020December 8, 2023March 31, 2022
    Comment
  • ICU beds in prioritized ICU units that are fully equipped and operationalValue0.0092.0070.00
    DateApril 1, 2020December 8, 2023March 31, 2022
    Comment
  • Percentage of population vaccinated, which is included in the priority population targets, as defined in the National Plan for the Introduction of the Vaccine against COVID-19Value0.0073.0065.00
    DateFebruary 8, 2021December 8, 2023October 31, 2024
    Comment
  • Percentage of female population vaccinated, which is included in the priority population targets, as defined in the National Plan for the Introduction of the Vaccine against COVID-19Value0.0066.0065.00
    DateFebruary 8, 2021March 3, 2023October 31, 2024
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Share of prioritized health facilities receiving the volume of PPEs planned under the projectValue0.00100.00100.00
    DateFebruary 9, 2021December 8, 2023March 31, 2023
    Comment
  • Health management and information system to deploy the COVID-19 vaccine is in place, including functionality for identification, registration, and follow-up with COVID-19 vaccine recipientsValueNoNoYes
    DateFebruary 8, 2021December 7, 2023October 31, 2024
    Comment
  • Share of vaccination leadership roles created by project financing filled by womenValue0.0064.0060.00
    DateFebruary 8, 2021December 7, 2023March 31, 2023
    Comment
  • Share of regional health authorities reports on corrective measures taken based on feedback from users of health facilities offering COVID-19 vaccination services published on SESAL's websiteValue0.00100.00100.00
    DateFebruary 8, 2021December 7, 2023March 31, 2023
    Comment